CVAid Medical

AI-based Stroke Disease Management Platform

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in October 2018 by Danny Farin, Oren Dror, Rotem Sivan-Hoffmann, and Nadav Eichler, CVAid Medical operates with 1–10 employees. The company has raised $4M across two funding rounds from four investors.

Business overview

CVAid Medical specializes in stroke telemedicine, developing an AI-based platform for comprehensive stroke diagnosis and disease management. The company's core product, CVA-Flow, is a telestroke system that facilitates early and accurate stroke diagnosis by certified neurology teams using smartphones and cloud servers. Supported by its CVA-Core AI module, the platform synchronizes all stroke stakeholders, from patients and EMS to hospitals and medical teams. CVAid Medical leverages a proprietary database of visual and auditory stroke patient recordings, along with machine and deep learning tools, to provide real-time data analysis and decision support for neurologists, serving the digital healthcare, digital medical diagnostics, and medical decision support sectors.

Strategic signal

This investment signals continued investor confidence in the company's AI-based stroke telemedicine platform and its potential to enhance early diagnosis and management of stroke, a critical area within digital healthcare.

Company Intelligence Q&A

What is CVAid Medical's primary focus?
CVAid Medical focuses on stroke telemedicine, aiming to improve stroke diagnosis and management through its AI-based platform.
When was CVAid Medical founded?
CVAid Medical was founded in October 2018.
Who are the founders of CVAid Medical?
The co-founders of CVAid Medical are Danny Farin, Oren Dror, Rotem Sivan-Hoffmann, and Nadav Eichler.
What is CVA-Flow?
CVA-Flow is CVAid Medical's comprehensive telestroke system designed for early and accurate stroke diagnosis by neurology teams using smartphones and cloud servers.
Which investors participated in CVAid Medical's February 2022 funding round?
In February 2022, CVAid Medical received funding from RAD BioMed and Phillips Ventures.

External links